. Overall, the survival rate was lower for patients in the expanded ECLS group (59% v 75%; P = .121). When the survival rates for patients supported with ECLS postoperatively were compared for the expanded and early groups, a significant difference (59% v 80%; P < .05) was noted. However, when ECLS patients with a best Paor of 150 mm Hg were excluded from this analysis, there was no significant difference between the two groups (74% v 80%). indicating that the inclusion of nonhoneymoon patients as potential ECLS candidates has accounted for a significant portion of the observed decrease in survival among CDH patients managed with ECLS. The survival rate of salvageable CDH patients with a best Paor of 550 mm Hg increased slightly for the expanded ECLS group, to 27% (4 of 15). versus 0% (0 of 2) for the early ECLS group. The authors conclude that a change in the population of CDH patients presenting to their institution along with application of ECLS to CDH patients without a honeymoon has resulted in a reduction in the survival rate, but has allowed only a modest 27% survival rate for patients who were previously considered nonsalvageable. 
I
N 1988, OUR GROUP reported an increase in the overall survival rate for infants with congenital diaphragmatic hernia (CDH), from 50% to 76%, through the application of extracorporeal life support (ECLS) in the setting of severe respiratory fai1ure.r At the time of our previous report, we commonly excluded patients from consideration for ECLS if they had never had a best postductal Pao2 of more than 50 mm Hg. It was believed that these patients had severe pulmonary hypoplasia, which would preclude recovery despite prolonged courses of ECLS. However, subsequent studies suggested that such criteria were nonspecific in predicting mortality and not appropriate for use as ECLS exclusion criteria.2 Therefore, in 1988, all patients with CDH who had persistent respiratory failure despite maximal conventional support were considered candidates for ECLS, provided their weight was more than 2 kg, their gestational age was more than 34 weeks, and they had no severe genetic anomalies or other abnormalities that would preclude viable existence. Herein we summarize our experience over the last 12 years, since ECLS has been available, and analyze the effect of such changes in ECLS selection criteria.
MATERIALS AND METHODS
We performed a retrospective review of the records of all patients with CDH treated at the University of Michigan Medical Center (UMMC), C.S. Mott Children's Hospital. from June 1981 to June 1993.
Before 1981, ECLS therapy was not available at our center for the management of CDH patients with severe pulmonary failure. Subsequent to 1981, all patients who had significant respiratory failure despite maximal therapy with conventional ventilatory and pharmacological support were considered for ECLS. Criteria that, on retrospective review, could reliably identify infants with projected mortality rates of 80% to 100% with conventional ventilatory support were used to select patients for treatment with ECLS.3. 4 The inclusion criteria include (1) acute deterioration, with Pao: of less than 40 mm Hg or pH of less than 7.15 for more than 2 hours: (2) oxygen index (01) of more than 40 on three of five measurements between 30 and 60 minutes apart (where 01 = FIO~ x mean airway pressure x 100, divided by postductal Paoz); or (3) severe barotrauma. Previously reported exclusion criteria were developed to eliminate patients from consideration for ECLS if reasonable expectation of meaningful survival could not be achieved.' The exclusion criteria were (1) age of more than 10 days; (2) gestational age of less than 35 weeks; (3) weight of less than 2 kg; (4) preexisting severe intracranial hemorrhage; (5) serious coexistent genetic anomaly; (6) uncorrectable cyanotic heart disease; (7) moribund condition: or (8) ongoing cardiopulmonary resuscitation before cannulation was begun. In our initial experience, patients were excluded from consideration for ECLS if they never had a postductal Paoa of more than 50 mm Hg (ie. if they never had "honeymoon" period). This exclusion criterion was applied to identify "unsalvageable" patients with bilateral pulmonary hypopla-sia. However, beginning in 1988, this exclusion criterion was no longer applied, and ECLS was then used in nonhoneymoon patients. Therefore, two eras, or groups, each with individual management strategies for CDH, were identified at our institution. Group 1 patients were treated from June 1981 to December 1987 ("early ECLS era"). Group 2 patients were treated from January 1988 to June 1993 ("expanded ECLS era").
An additional difference in management strategy between the early and expanded ECLS groups lies in the timing of operative repair. Before 1988, all patients were operated on as soon as it was feasible; ECLS was used only in the postoperative period. When we expanded our criteria for ECLS, it was noted that newborns with severe respiratory insufficiency would not be able to tolerate surgery unless bypass was initiated preoperatively. Therefore, we began to institute ECLS in these neonates emergently, and the operation was performed while they were on ECLS support. More recently, in 1993, we began to attempt to wean these patients from ECLS support before operative repair. Therefore, all ECLS patients in group 1 had repair before ECLS, but patients in group 2 could be repaired pre-ECLS, on ECLS, or post-ECLS.
The two groups of patients were assessed for differences in severity of illness and differences in survival rates. Data were compared using Fisher's exact test and x2 analysis.
RESULTS
Between June 1981 and June 1993, 111 patients with CDH diagnosed in the first 24 hours of life were treated at the University of Michigan, C.S. Mott Children's Hospital. Thirty-six of them were treated from June 1981 to December 1987 (early ECLS era; group l), and 75 were treated from January 1988 to June 1993 (expanded ECLS era; group 2). Therefore, the number of CDH patients managed each year at our institution increased from 6 per year (1981 to 1987) to 14 per year (1988 to 1993) over the study period.
Twenty-six of the 36 patients (72%) in the early ECLS group were born at outlying hospitals; seven of whom (27%) underwent operative repair before being transferred to our facility. In the current expanded ECLS era, 52 of 75 (70%) were born at outlying hospitals, 16 of whom (31%) had repair before transport.
Between the time periods, there was a substantial increase in the proportion of patients for whom the diagnosis was made in utero. In the early ECLS era, eight patients were identified as having CDH based on prenatal ultrasound examination (8 of 36; 22%); seven of these patients were delivered at our institution. In group 2,30 patients had the diagnosis made in utero (30 of 75; 40%); 20 of them were delivered at our institution. Another 14 patients in this group had undergone prenatal ultrasound examination, and CDH had not been detected.
As seen in Table 1 , there were no significant differences between the two groups in terms of gestational age or birth weight. There was also no significant difference in the percentage of patients with associated anomalies or in the percentage who had a left-sided hernia. The proportion of patients who met criteria for and in whom ECLS was used increased with time, as did the proportion of CDH patients who required a muscle flap or prosthetic reconstruction of the diaphragm at the time of CDH repair. In addition, the proportion of patients with a best Pao2 of I 50 mm Hg increased substantially (6% for the early ECLS group, 28% for the expanded ECLS group). The survival rates appear in Table 2 . In the early ECLS group, overall survival was 27 of 36 (75%). Of the 27, 20 were treated postoperatively with conventional ventilation alone, and 15 survived (75%). In addition, 12 of 15 patients treated postoperatively with ECLS survived (80%). Of the six patients who died without the use of ECLS, two were excluded because their best Paoz did not exceed 50 mm Hg, two because of genetic anomalies, and two because of prematurity.
In the expanded ECLS group, overall survival was 44 of 75 (59%). Seventeen of the 44 were treated with conventionalventilation alone, and 15 survived (88%). The total number of patients treated with ECLS was 49; of these, 29 survived (59%). These survival rates are lower than those for the early ECLS group; however, the difference was not significant (Fig 1) . Twenty-nine patients had repair before initiation of ECLS, with 21 survivors (72%). Seventeen patients had repair while on ECLS, with six survivors (35%). Three patients were weaned from ECLS before CDH repair was attempted, with two survivors (67%). The extension of ECLS to patients with more severe respiratory failure clearly diminished survival in the group treated with ECLS. In the expanded ECLS group, there were 21 patients with a best postductal Paoz of 150. However, only 15 were placed on ECLS; the remainder were excluded by other criteria. Four of these survived (27%). These patients would have been excluded from ECLS under our previous criteria. There was a significant difference in the survival rates between patients managed with ECLS in the expanded era and those managed in the early era (59% v 80%; P < .05). However, when only the patients whose best Paoz exceeded 50 mm Hg (managed with ECLS) were considered, there was no significant difference between the survival rates (80% for the early group, 74% for the expanded group). The period of time on ECLS for patients whose best Paoz was I 50 mm Hg was 14.5 + 7.1 days; this is significantly different from that of patients with a best Paoz of more than 50 mm Hg (9.9 + 6.5 days; P < .05). The average hospital stay for the four survivors whose best Pao2 was 550 mm Hg was 2 months (range, 31 to 99 days). The mean period of hospitalization did not differ significantly between these patients and those whose best Pao2 exceeded 50 mm Hg (52 ? 31 days v 49 -c 51 days). Follow-up of these four survivors (at 18 to 30 months) showed that one died at home of unknown causes a few months after hospital discharge. One required a fundoplication for gastroesophageal reflux (GER), but is otherwise well. One child is slightly delayed neurologically and has reactive airway disease. This patient also had findings of GER and underwent a fundoplication procedure. The fourth child is normal. None of the three surviving patients currently requires supplemental oxygen.
It is interesting to note that the patients for whom CDH was diagnosed in utero in the early ECLS era all had a best Paoz of more than 50 mm Hg, and their overall survival rate was 75% (six of eight). However, for the expanded ECLS group, only 17 of 30 (57%) had a best Pao? of more than 50 mm Hg, with an overall survival rate of 37% (11 of 30).
Seventeen patients had CDH repair while on ECLS support; there were six survivors (35%) in the expanded ECLS era. Ten of the 17 had a best Paoz of I 50 mm Hg; four of the 10 survived. Figure 2 shows the survival data for the patients repaired before and during ECLS.
The incidence of significant complications during ECLS was low in both eras. Major bleeding was the most common complication, occurring in four patients in the early era (26%) and four in the expanded era (8%). In the expanded era, three children were removed from ECLS because of severe intracranial hemorrhage. A fourth child had severe postoperative bleeding, which required discontinuation of ECLS; that child subsequently died of respiratory insufficiency. There were no other complications of ECLS that directly contributed to patient death. In addition, there were no mechanical complications of ECLS that resulted in patient death.
In the early ECLS era, there were nine deaths. Six of the nine children who died were excluded from ECLS support; two of these were premature, two had genetic anomalies, and two did not have a postductal Paoz of more than 50 mm Hg. One child died of intracranial hemorrhage while on ECLS support. The other two deaths occurred late-one secondary to Fig 2. Expanded ECLS (1988-1993) . Survival rates for patients treated with ECLS before or during CDH repair. Patients repaired while on ECLS had a significantly lower survival rate than those repaired before ECLS.
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sepsis, and the other because of bronchopulmonary dysplasia (BPD).
In the expanded ECLS era, there were 31 deaths. Ten occurred in patients who were excluded from ECLS support because of prematurity (4), multiple anomalies (3), pre-ECLS cardiac arrest (2), or intraoperative death (1). One death occurred late, in a child who had been transferred to another hospital for care; she died of acute onset of respiratory failure, which was attributed to BPD. The causes of death for the 20 patients managed with ECLS included persistent respiratory failure (7), bleeding complications (5), sequelae of ischemic neurological injury (3), necrotizing enterocolitis (2), and multisystem organ failure (3). All three in the latter group had had renal failure during ECLS. Two had concomitant persistent respiratory failure, but one had been successfully weaned from ECLS and died 12 days later, after the development of sepsis from acalculous cholecystitis.
DISCUSSION
Reports of survival of CDH patients published from 1965 to 1985 show mortality rates in the range of 50%.' The causes of death can be grouped as follows: (1) pulmonary hypoplasia, (2) persistent pulmonary hypertension of the newborn, and (3) associated anomalies.5 ECLS was introduced to support the neonate while persistent pulmonary hypertension resolves.
Selection of patients for treatment with ECLS has been a topic of great debate. Multiple criteria have been developed by Bohn et al, Stolar et al, and others, which serve as predictors of high mortality in the CDH patient managed with conventional mechanical ventilation.6,7 However, although these various criteria appear to have relevance in terms of predicting those who will die with conventional support alone, the issue of which patients will succumb even if more aggressive intervention is instituted (such as ECLS) remains unresolved. Attempts to develop criteria that identify patients with inadequate lung parenchyma to support life have generally been unsuccessfu12,* Consequently, most centers have begun to offer ECLS support to any neonate with CDH for whom conventional mechanical ventilatory support has failed.
In 1988, at our institution, we began to use ECLS support in any neonate for whom conventional mechanical ventilatory support had failed. A review of our survival data since that time, as compared with our previous survival figures, indicates that overall survival has diminished since the change was instituted (59% v 75%), although this difference is not statistically significant. In addition, the survival rate for all patients managed with ECLS decreased significantly between the early and expanded eras, whereas the survival rate for those whose best Pao2 exceeded 50 mm Hg has not decrease significantly. These data allow us to conclude that it is the inclusion of these more severely affected newborns that has accounted for the major portion of the observed decrease in survival among patients managed with ECLS. Expansion of criteria to include CDH patients with a best Paoz of 150 mm Hg has resulted in only a small (27%) increase in survival among the patients who were previously considered unsalvageable. As is evident from the long courses on ECLS and the prolonged hospital stay for survivors, considerable resources are expended in an attempt to salvage very few patients. We believe that patients with a best Pao, of 150 mm Hg remain relatively poor candidates for ECLS and that each center should evaluate whether their experience in this high-mortality group warrants the continued inclusion of such patients as ECLS candidates.
The number of cases diagnosed in utero has increased dramatically, from eight (22%) in the early ECLS era to 30 (44%) in the expanded era. All eight of the early patients had a best Pao2 of more than 50 mm Hg; only three required ECLS support, and six of the eight (75%) survived. In contrast, in the expanded era, only 17 of 30 (57%) had a best Pao2 of more than 50 mm Hg, and survival was only 11 of 30 (37%). It is evident that the recent application of in utero ultrasonography has led to an increase in the severity of respiratory insufficiency of CDH patients managed at our institution. We suggest that this is because of changes in perinatal referral patterns, which have led to more expeditious and efficient transfer, either before or after birth, of the fetus/newborn with known CDH. In utero diagnosis is also responsible for the increase in referrals to our institution (from 36 patients in the early era to 75 in the expanded era).
The timing of surgical repair for infants with CDH has been a subject of recent debate. Traditionally, emergency surgical repair of CDH has been performed to reduce the herniated viscera, to eliminate the risk of bowel incarceration, and to eliminate compression of the lungs and resultant poor gas exchange. However, surgical repair of CDH has been shown to result in a reduction in pulmonary compliance. 9 In already marginally ventilating infants, this decreased compliance can have severe clinical consequences. Bohn et al suggested that delayed surgical repair might allow reversal of pulmonary artery hypertension and improved survival6 However, some in-fants are not able to oxygenate and ventilate adcondition are maintained in the neonatal intensive equately at the time of initial presentation. Our care unit and are electively repaired before extubacurrent protocol allows placement of such infants on tion, usually when they are at least 72 hours of age. ECLS, with delay in operative repair until the pa-
The effect of this approach on the outcome of tients can be successfully weaned from ECLS supnewborns with CDH managed at our institution is yet port. Infants who present to our center in stable to be determined.
